BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 18376281)

  • 1. The age incidence of childhood B-cell precursor acute lymphoblastic leukemia in Mexico City.
    Bernaldez-Rios R; Ortega-Alvarez MC; Perez-Saldivar ML; Alatoma-Medina NE; Del Campo-Martinez Mde L; Rodriguez-Zepeda Mdel C; Montero-Ponce I; Franco-Ornelas S; Fernandez-Castillo G; Nuñez-Villegas NN; Taboada-Flores MA; Flores-Lujano J; Argüelles-Sanchez ME; Juarez-Ocaña S; Fajardo-Gutierrez A; Mejia-Arangure JM
    J Pediatr Hematol Oncol; 2008 Mar; 30(3):199-203. PubMed ID: 18376281
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Immunophenotyping of acute lymphoblastic leukemia in Mexican children].
    Paredes-Aguilera R; Romero-Guzmán L; López-Santiago N; Bravo-Lindoro A; Correa-González C; Joly-Linero R; Nieto-Martínez S; del Campo-Martínez A
    Sangre (Barc); 1999 Jun; 44(3):188-94. PubMed ID: 10481579
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical relevance of CD10 expression in childhood ALL. The Italian Association for Pediatric Hematology and Oncology (AIEOP).
    Consolini R; Legitimo A; Rondelli R; Guguelmi C; Barisone E; Lippi A; Cantù-Rajnoldi A; Aricò M; Conter V; Cocito MG; Putti MC; Pession A; Masera G; Biondi A; Basso G
    Haematologica; 1998 Nov; 83(11):967-73. PubMed ID: 9864914
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence trends of acute leukemia among the children of Mexico City: 1982-1991.
    Mejía-Aranguré JM; Fajardo-Gutiérrez A; Bernáldez-Ríos R; Farfán-Canto JM; Ortíz-Fernández A; Martínez-García MD
    Arch Med Res; 1996; 27(2):223-7. PubMed ID: 8696068
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The incidence peaks of the childhood acute leukemias reflect specific cytogenetic aberrations.
    Forestier E; Schmiegelow K;
    J Pediatr Hematol Oncol; 2006 Aug; 28(8):486-95. PubMed ID: 16912588
    [TBL] [Abstract][Full Text] [Related]  

  • 6. B-lineage acute lymphoblastic leukemia of childhood. An institutional experience.
    Rivera-Luna R; Cardenas-Cardos R; Leal-Leal C; Navarro-Alegría I; Meza-Coria C; Gómez-Martínez R; Vega-Vega L
    Arch Med Res; 1997; 28(2):233-9. PubMed ID: 9204615
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [ALL-XH-99 protocol in the treatment of childhood T-cell acute lymphoblastic leukemia].
    Ye QD; Gu LJ; Tang JY; Xue HL; Chen J; Pan C; Chen J; Dong L; Zhou M
    Zhonghua Xue Ye Xue Za Zhi; 2009 Jan; 30(1):26-8. PubMed ID: 19563031
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biological and clinical features of B-precursor childhood acute lymphoblastic leukemia showing CD2 and/or E-rosette co-expression.
    Cantù-Rajnoldi A; Putti MC; Schirò R; Biondi A; Cattoretti G; Valeggio C; Castagni M; Basso G
    Haematologica; 1992; 77(5):384-91. PubMed ID: 1362385
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic impact of age in children and adolescents with acute lymphoblastic leukemia: data from the trials ALL-BFM 86, 90, and 95.
    Möricke A; Zimmermann M; Reiter A; Gadner H; Odenwald E; Harbott J; Ludwig WD; Riehm H; Schrappe M
    Klin Padiatr; 2005; 217(6):310-20. PubMed ID: 16307416
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mixed chimerism in the B cell lineage is a rapid and sensitive indicator of minimal residual disease in bone marrow transplant recipients with pre-B cell acute lymphoblastic leukemia.
    Zetterquist H; Mattsson J; Uzunel M; Näsman-Björk I; Svenberg P; Tammik L; Bayat G; Winiarski J; Ringdén O
    Bone Marrow Transplant; 2000 Apr; 25(8):843-51. PubMed ID: 10808205
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Prevalence and features of pre-B-cell acute lymphoblastic leukemia in Mexico: description of 9 patients].
    Lobato-Mendizábal E; Ruiz-Argüelles GJ
    Sangre (Barc); 1991 Feb; 36(1):1-5. PubMed ID: 1906639
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Immunophenotype. Clinical and laboratory features of acute lymphoblastic leukemia in Chile. Study of 500 children and 131 adults].
    Cabrera ME; Labra S; Ugarte S; Matutes E; Greaves MF
    Rev Med Chil; 1996 Mar; 124(3):293-9. PubMed ID: 9008940
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunologic profile and outcome of childhood acute lymphoblastic leukemia (ALL) in Morocco.
    Dakka N; Bellaoui H; Khattab M; Brahimi-Horn MC; Aoued L; Bouzid N; Bakri Y; Benjouad A
    J Pediatr Hematol Oncol; 2007 Aug; 29(8):574-80. PubMed ID: 17762501
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The incidence of T-cell receptor gene rearrangements in childhood B-lineage acute lymphoblastic leukemia is related to immunophenotype and fusion oncogene expression.
    Meleshko AN; Belevtsev MV; Savitskaja TV; Potapnev MP
    Leuk Res; 2006 Jul; 30(7):795-800. PubMed ID: 16386788
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Significance of the complete clearance of peripheral blasts after 7 days of prednisolone treatment in children with acute lymphoblastic leukemia: the Tokyo Children's Cancer Study Group Study L99-15.
    Manabe A; Ohara A; Hasegawa D; Koh K; Saito T; Kiyokawa N; Kikuchi A; Takahashi H; Ikuta K; Hayashi Y; Hanada R; Tsuchida M;
    Haematologica; 2008 Aug; 93(8):1155-60. PubMed ID: 18519521
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Childhood acute leukemias are frequent in Mexico City: descriptive epidemiology.
    Pérez-Saldivar ML; Fajardo-Gutiérrez A; Bernáldez-Ríos R; Martínez-Avalos A; Medina-Sanson A; Espinosa-Hernández L; Flores-Chapa Jde D; Amador-Sánchez R; Peñaloza-González JG; Alvarez-Rodríguez FJ; Bolea-Murga V; Flores-Lujano J; Rodríguez-Zepeda Mdel C; Rivera-Luna R; Dorantes-Acosta EM; Jiménez-Hernández E; Alvarado-Ibarra M; Velázquez-Aviña MM; Torres-Nava JR; Duarte-Rodríguez DA; Paredes-Aguilera R; Del Campo-Martínez Mde L; Cárdenas-Cardos R; Alamilla-Galicia PH; Bekker-Méndez VC; Ortega-Alvarez MC; Mejia-Arangure JM
    BMC Cancer; 2011 Aug; 11():355. PubMed ID: 21846410
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gender differences in incidence rates of childhood B-precursor acute lymphocytic leukemia in Mississippi.
    Forsythe A; Breland T; Majumdar S; Elkin TD; Johnson D; Megason G
    J Pediatr Oncol Nurs; 2010; 27(3):164-7. PubMed ID: 20164246
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression of CD49f in precursor B-cell acute lymphoblastic leukemia: potential usefulness in minimal residual disease detection.
    DiGiuseppe JA; Fuller SG; Borowitz MJ
    Cytometry B Clin Cytom; 2009 Mar; 76(2):150-5. PubMed ID: 18831072
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic value of karyotypic analysis in children and adults with high-risk acute lymphoblastic leukemia included in the PETHEMA ALL-93 trial.
    Ribera JM; Ortega JJ; Oriol A; Granada I; Hernández-Rivas JM; Parody R; Bethencourt C; Rivas C; Bastida P; del Potro E; González-Valentín ME; Moreno MJ; Besalduch J; Fernández-Calvo J; Tormo M; Arias J; Molinés A; Sanz MA; Maldonado J; Millá F; Feliu E; San Miguel JF;
    Haematologica; 2002 Feb; 87(2):154-66. PubMed ID: 11836166
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical characteristics of children with B cell type acute lymphoblastic leukemia carrying different fusion gene].
    Zuo YX; Zhang LP; Lu AD; Wang B; Liu GL
    Zhongguo Dang Dai Er Ke Za Zhi; 2010 Mar; 12(3):172-6. PubMed ID: 20350423
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.